Biopharmaceuticals Manufacturing Consumables Testing Business Research Report 2024-2030
October 18, 2024 04:30 ET
|
Research and Markets
Dublin, Oct. 18, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Manufacturing Consumables Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More
October 14, 2024 11:15 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Peptide...
Biopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug Developments
October 14, 2024 10:58 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ...
Peptide Therapeutics Market and Industry Forecast 2024-2032: Total Revenues Forecast to Reach $86.9 Billion by 2032, Dominated by Pfizer, AstraZeneca, Roche, Novo Nordisk and Teva Pharmaceuticals
October 10, 2024 06:34 ET
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2024-2032"...
Proteinuria Therapeutics Strategic Business Report 2024: Innovations in Biomarker-Based Diagnosis Sustain Growth in Proteinuria Therapeutics Market - Forecasts to 2030
October 01, 2024 13:02 ET
|
Research and Markets
Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "Proteinuria Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Proteinuria...
Microbiome Therapeutics Market Forecast at $21.5 Billion by 2030, Witnessing a 56.9% CAGR - Rising Prevalence of Gastrointestinal Disorders Driving Demand
September 30, 2024 06:05 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Microbiome Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Biopharmaceutical Processing Equipment and Consumables Research Report 2024-2031: Lucrative Opportunities in Emerging Economies, Shift Toward Bioprocessing 4.0, & Adoption of Personalized Medicines
September 25, 2024 08:02 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type, Application - Global...
Microcarriers Market to hit USD 4 billion by 2032, says Global Market Insights Inc.
September 25, 2024 05:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Microcarriers Market size is estimated to reach USD 4 billion by the end of 2032 driven by the rising demand for cell-based therapies and...
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
September 08, 2024 19:10 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Sept. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative...
Antibody Drug Conjugates Market Is Expected To Reach Revenue Of USD 51.2 Bn By 2033, at 15.8% CAGR: Dimension Market Research
September 05, 2024 11:45 ET
|
Dimension Market Research
New York, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Overview The Global Antibody Drug Conjugates (ADCs) Market is projected to grow from USD 13.7 billion in 2024 to USD 51.2 billion by 2033, at a CAGR...